Home > Healthcare > Medical Devices > Diagnostic Devices > Continuous Glucose Monitoring Market

Continuous Glucose Monitoring Market Share

Report ID: GMI6109
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Continuous Glucose Monitoring Market Share

Some of the notable key industry players operating in the continuous glucose monitoring market include

Lifescan, Inc.
Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.)
Nova Biomedical
Universal Biosensors
Taidoc Technology Corporation
Med Trust
Roche AG
Dexcom
Abbott
i-SENS, Inc.
Trividia Health
Medtronic
Pinnacle technology

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market size for continuous glucose monitoring was USD 6.8 billion in 2023 and is projected to reach USD 20.2 billion by 2032, driven by the increasing number of type 1 and type 2 diabetes patients globally.

The sensors component segment generated USD 2.8 billion in 2022 and is poised to record substantial growth through 2032 owing to the rising need for early detection of hypoglycemia

U.S. industry amassed USD 2 billion in 2022 and is projected to grow at a notable CAGR through 2032 owing to the ongoing technological developments, rising healthcare spending, and the presence of well-established market participants in the country.

Some of the prominent companies in the continuous glucose monitoring market are Lifescan, Inc., Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.), Universal Biosensors, Taidoc Technology Corporation, Med Trust, Roche AG., Dexcom, Abbott, i-SENS, Inc., Trividia Health, and Medtronic,